diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM12504diaendo-12504Research ArticleКлинические рекомендацииClinical GuidelinesСахарный диабет 1 типа у детейDiabetes mellitus type 1 in childhoodhttps://orcid.org/0000-0002-5507-4627ПетерковаВалентина АлександровнаPeterkovaValentina A.

д.м.н., профессор, академик РАН, научный руководитель Института детской эндокринологии

MD, PhD, professor, academician of RAS

peterkovava@hotmail.comhttps://orcid.org/0000-0003-3893-9972ШестаковаМарина ВладимировнаShestakovaMarina V.

д.м.н., профессор, академик РАН

MD, PhD, Professor

nephro@endocrincentr.ruhttps://orcid.org/0000-0001-9621-5732Безлепкина Ольга БорисовнаBezlepkinaOlga B.

д.м.н., профессор, заместитель директора Центра по научно-лечебной работе

MD, PhD, Professor

olgabezlepkina@mail.ruhttps://orcid.org/0000-0002-4316-8546ЛаптевДмитрий НикитичLaptevDmitry N.

Кандидат медицинских наук, заведующий детским отделением сахарного диабета Института детской эндокринологии

PhD, Head of the Department of Pediatric Diabetes

laptevdn@ya.ruhttps://orcid.org/0000-0003-4950-3920КураеваТамара ЛеонидовнаKuraevaTamara L.

д.м.н., проф.

MD, PhD, Professor

diabetkuraeva@mail.ruhttps://orcid.org/0000-0001-5825-3287МайоровАлександр ЮрьевичMayorovAleksandr Y.

д.м.н.

MD, PhD

education@endocrincentr.ruhttps://orcid.org/0000-0001-7821-3979ТитовичЕлена ВитальевнаTitovichElena V.

к.м.н.

MD, PhD

lenatitovich@mail.ruhttps://orcid.org/0000-0002-3742-0231ЕмельяновАндрей ОлеговичEmelyanovAndrey O.

кандидат медицинских наук, ведущий научный сотрудник Института детской эндокринологии

PhD, senior scientist, Department of Pediatrics

endiab@mail.ruhttps://orcid.org/0000-0002-4328-2090СветловаГалина НиколаевнаSvetlovaGalina N.

к.м.н.

MD, PhD

g_svetlova@mail.ruhttps://orcid.org/0000-0003-2333-3935ЕреминаИрина АлександровнаEreminaIrina Aleksandrovna

Научный сотрудник детского отделния сахарного диабета Института детской эндокринологии ФГБУ ЭНЦ МЗ РФ

MD

ieremina58@gmail.comhttps://orcid.org/0000-0003-3230-1337АлимоваИрина ЛеонидовнаAlimovaIrina L.

доктор медицинских наук, профессор, заведующая кафедрой госпитальной педиатрии с курсом неонатологии ФДПО

MD, PhD, Professor

iri-alimova@yandex.ruhttps://orcid.org/0000-0002-7063-1161БашнинаЕлена БорисовнаBashninaElena B.

д.м.н., профессор

MD, PhD, Professor

bashnina@mail.ruhttps://orcid.org/0000-0002-8148-526XБолотоваНина ВикторовнаBolotovaNina V.

д.м.н., профессор

MD, PhD, Professor

kafedranv@mail.ruГалкинаГалина АлександровнаGalkinaGalina A.

д.м.н., профессор, заведующая детским эндокринным отделением НИИ акушерства и педиатрии

MD, professor, head of the children's endocrine department of the Research Institute of Obstetrics and Pediatrics

kafedranv@mail.ruhttps://orcid.org/0000-0003-0112-3785КостроваИрина БорисовнаKostrovaIrina B.

к.м.н., заведующая отделением детской эндокринологии, главный внештатный специалист (Республика Дагестан), главный внештатный специалист Северо-Кавказского ФО

ira_kostrova@mail.ruhttps://orcid.org/0000-0003-2599-0867МалиевскийОлег АртуровичМalievskyOleg A.

профессор

MD, PhD, Professor

malievsky@list.ruhttps://orcid.org/0000-0002-8520-2378ПетряйкинаЕлена ЕфимовнаPetriaikinaElena E.

д.м.н.

MD

lepet_morozko@mail.ruhttps://orcid.org/0000-0003-0208-4116СамсоноваЛюбовь НиколаевнаSamsonovaLubov N.

доктор медицинских наук, заведующий кафедрой детской эндокринологии, декан педиатрического факультета

MD, PhD, professor

elvkasatkina@yandex.ruhttps://orcid.org/0000-0001-8968-3925ХрамоваЕлена БорисовнаKhramovaElena B.

д.м.н.

MD, PhD, assistant professor

doctor.khramova@gmail.comНациональный медицинский исследовательский центр эндокринологииРоссияEndocrinology Research centreRussian FederationНациональный медицинский исследовательский центр эндокринологииРоссияEndocrinology Research CentreRussian FederationНациональный медицинский центр эндокринологииРоссияEndocrinology Research CentreRussian FederationФГБОУ ВО «Смоленский государственный медицинский университет»РоссияSmolensk State Medical UniversityRussian FederationФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава РоссииРоссияNorth-Western State Medical University named after I.I. MechnikovRussian FederationФГБУ ВО «Саратовский государственный медицинский университет им. В.И. Разумовского» Минздрава РоссииРоссияV.I. Razumovskiy Saratov State Medical UniversityRussian FederationФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава РоссииРоссияRostov State Medical UniversityRussian FederationГБУ «Детская республиканская клиническая больница им. Н.М. Кураева»РоссияChildren's Republic hospitalRussian FederationФГБОУ ВО Башкирский государственный медицинский университет Минздрава РоссииРоссияBashkortostan State Medical UniversityRussian FederationГБУЗ Морозовская детская городская клиническая больница Департамента здравоохранения г. МосквыРоссияMorozov Children's Municipal Clinical Hospital of the Moscow City Health DepartmentRussian FederationРоссийская медицинская академия непрерывного профессионального образованияРоссияRussian Medical Academy of Continuous Professional EducationRussian FederationФГБОУ ВО «Тюменский государственный медицинский университет» Минздрава РоссииРоссияTyumen State Medical UniversityRussian Federation202022062020231SКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ. САХАРНЫЙ ДИАБЕТ 1 ТИПА У ДЕТЕЙ. САХАРНЫЙ ДИАБЕТ 1 ТИПА У ВЗРОСЛЫХ440Copyright © Петеркова В.А., Шестакова М.В., Безлепкина  О.Б., Лаптев Д.Н., Кураева Т.Л., Майоров А.Ю., Титович Е.В., Емельянов А.О., Светлова Г.Н., Еремина И.А., Алимова И.Л., Башнина Е.Б., Болотова Н.В., Галкина Г.А., Кострова И.Б., Малиевский О.А., Петряйкина Е.Е., Самсонова Л.Н., Храмова Е.Б., 20202020Петеркова В.А., Шестакова М.В., Безлепкина  О.Б., Лаптев Д.Н., Кураева Т.Л., Майоров А.Ю., Титович Е.В., Емельянов А.О., Светлова Г.Н., Еремина И.А., Алимова И.Л., Башнина Е.Б., Болотова Н.В., Галкина Г.А., Кострова И.Б., Малиевский О.А., Петряйкина Е.Е., Самсонова Л.Н., Храмова Е.Б.Peterkova V.A., Shestakova M.V., Bezlepkina O.B., Laptev D.N., Kuraeva T.L., Mayorov A.Y., Titovich E.V., Emelyanov A.O., Svetlova G.N., Eremina I.A., Alimova I.L., Bashnina E.B., Bolotova N.V., Galkina G.A., Kostrova I.B., Мalievsky O.A., Petriaikina E.E., Samsonova L.N., Khramova E.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/12504

Общественная организация «Российская ассоциация эндокринологов». Клинические рекомендации. 

Public organization “Russian Association of Endocrinologists”. Clinical guidlines.

Сахарный диабет 1 типадетиклинические рекомендацииDiabetes mellitus type 1childrenclinical recommendationsReferencesStaging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association / R.A. Insel [et al.] // Diabetes Care. – 2015. – Vol. 38. – № 10. – P. 1964-1974.Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association / R.A. Insel [et al.] // Diabetes Care. – 2015. – Vol. 38. – № 10. – P. 1964-1974.Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children / A.G. Ziegler [et al.] // JAMA. – 2013. – Vol. 309. – № 23. – P. 2473.Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children / A.G. Ziegler [et al.] // JAMA. – 2013. – Vol. 309. – № 23. – P. 2473.Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013–2016) / A.Y. Mayorov [и др.] // Diabetes mellitus. – 2019. – Т. 21. – № 6. – С. 444-454.Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013–2016) / A.Y. Mayorov [и др.] // Diabetes mellitus. – 2019. – Т. 21. – № 6. – С. 444-454.Trends in the epidemiology of diabetic retinopathy in Russian Federation according to the Federal Diabetes Register (2013–2016) / D.V. Lipatov [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 4. – С. 230-240.Trends in the epidemiology of diabetic retinopathy in Russian Federation according to the Federal Diabetes Register (2013–2016) / D.V. Lipatov [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 4. – С. 230-240.Trends in the epidemiology of diabetic foot and lower limb amputations in Russian Federation according to the Federal Diabetes Register (2013–2016) / G.R. Galstyan [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 3. – С. 170-177.Trends in the epidemiology of diabetic foot and lower limb amputations in Russian Federation according to the Federal Diabetes Register (2013–2016) / G.R. Galstyan [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 3. – С. 170-177.Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016) / M.S. Shamkhalova [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 3. – С. 160-169.Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016) / M.S. Shamkhalova [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 3. – С. 160-169.Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013–2016 / I.I. Dedov [и др.] // Diabetes mellitus. – 2018. – Т. 20. – № 6. – С. 392-402.Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013–2016 / I.I. Dedov [и др.] // Diabetes mellitus. – 2018. – Т. 20. – № 6. – С. 392-402.Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017 / I.I. Dedov [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 3. – С. 144-159.Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017 / I.I. Dedov [и др.] // Diabetes mellitus. – 2018. – Т. 21. – № 3. – С. 144-159.ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents / E.J. Mayer-Davis [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 7-19.ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents / E.J. Mayer-Davis [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 7-19.American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 / American Diabetes Association // Diabetes Care. – 2018. – Vol. 41. – № Supplement 1. – P. S13-S27.American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 / American Diabetes Association // Diabetes Care. – 2018. – Vol. 41. – № Supplement 1. – P. S13-S27.World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation / World Health Organization, International Diabetes Federation. – 2006.World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation / World Health Organization, International Diabetes Federation. – 2006.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review / R.A. Watkins [et al.] // Translational Research: The Journal of Laboratory and Clinical Medicine. – 2014. – Vol. 164. – № 2. – P. 110-121.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review / R.A. Watkins [et al.] // Translational Research: The Journal of Laboratory and Clinical Medicine. – 2014. – Vol. 164. – № 2. – P. 110-121.Etiological Approach to Characterization of Diabetes Type: The SEARCH for Diabetes in Youth Study / D. Dabelea [et al.] // Diabetes Care. – 2011. – Vol. 34. – № 7. – P. 1628-1633.Etiological Approach to Characterization of Diabetes Type: The SEARCH for Diabetes in Youth Study / D. Dabelea [et al.] // Diabetes Care. – 2011. – Vol. 34. – № 7. – P. 1628-1633.ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth / P. Zeitler [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 28-46.ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth / P. Zeitler [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 28-46.Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality / Writing Group for the DCCT/EDIC Research Group [et al.] // JAMA. – 2015. – Vol. 313. – № 1. – P. 45-53.Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality / Writing Group for the DCCT/EDIC Research Group [et al.] // JAMA. – 2015. – Vol. 313. – № 1. – P. 45-53.Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort / Writing Team for the DCCT/EDIC Research Group [et al.] // JAMA ophthalmology. – 2016. – Vol. 134. – № 2. – P. 137-145.Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort / Writing Team for the DCCT/EDIC Research Group [et al.] // JAMA ophthalmology. – 2016. – Vol. 134. – № 2. – P. 137-145.Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012 / B. Karges [et al.] // PLoS medicine. – 2014. – Vol. 11. – № 10. – P. e1001742.Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012 / B. Karges [et al.] // PLoS medicine. – 2014. – Vol. 11. – № 10. – P. e1001742.ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes / L.A. DiMeglio [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 105-114.ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes / L.A. DiMeglio [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 105-114.Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes / A. Fritsche [et al.] // Annals of Internal Medicine. – 2001. – Vol. 134. – № 9 Pt 1. – P. 729-736.Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes / A. Fritsche [et al.] // Annals of Internal Medicine. – 2001. – Vol. 134. – № 9 Pt 1. – P. 729-736.Both the frequency of HbA1c testing and the frequency of self-monitoring of blood glucose predict metabolic control: A multicentre analysis of 15 199 adult type 1 diabetes patients from Germany and Austria / A. Schwandt [et al.] // Diabetes/Metabolism Research and Reviews. – 2017. – Vol. 33. – № 7.Both the frequency of HbA1c testing and the frequency of self-monitoring of blood glucose predict metabolic control: A multicentre analysis of 15 199 adult type 1 diabetes patients from Germany and Austria / A. Schwandt [et al.] // Diabetes/Metabolism Research and Reviews. – 2017. – Vol. 33. – № 7.Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control / O.J. Driskell [et al.] // Diabetes Care. – 2014. – Vol. 37. – № 10. – P. 2731-2737.Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control / O.J. Driskell [et al.] // Diabetes Care. – 2014. – Vol. 37. – № 10. – P. 2731-2737.A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus / M. Liu [et al.] // BMC endocrine disorders. – 2016. – Vol. 16. – № 1. – P. 67.A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus / M. Liu [et al.] // BMC endocrine disorders. – 2016. – Vol. 16. – № 1. – P. 67.Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus / E. Schober [et al.] // Journal of pediatric endocrinology & metabolism: JPEM. – 2002. – Vol. 15. – № 4. – P. 369-376.Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus / E. Schober [et al.] // Journal of pediatric endocrinology & metabolism: JPEM. – 2002. – Vol. 15. – № 4. – P. 369-376.Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes / T. Danne [et al.] // Diabetes Care. – 2005. – Vol. 28. – № 9. – P. 2100-2105.Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes / T. Danne [et al.] // Diabetes Care. – 2005. – Vol. 28. – № 9. – P. 2100-2105.Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal–Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes / A. Philotheou [et al.] // Diabetes Technology & Therapeutics. – 2011. – Vol. 13. – № 3. – P. 327-334.Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal–Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes / A. Philotheou [et al.] // Diabetes Technology & Therapeutics. – 2011. – Vol. 13. – № 3. – P. 327-334.Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents / J.H. Holcombe [et al.] // Clinical Therapeutics. – 2002. – Vol. 24. – № 4. – P. 629-638.Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents / J.H. Holcombe [et al.] // Clinical Therapeutics. – 2002. – Vol. 24. – № 4. – P. 629-638.Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus / S. Tupola [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2001. – Vol. 18. – № 8. – P. 654-658.Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus / S. Tupola [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2001. – Vol. 18. – № 8. – P. 654-658.Effectiveness of postprandial Humalog in toddlers with diabetes / K.S. Rutledge [et al.] // Pediatrics. – 1997. – Vol. 100. – № 6. – P. 968-972.Effectiveness of postprandial Humalog in toddlers with diabetes / K.S. Rutledge [et al.] // Pediatrics. – 1997. – Vol. 100. – № 6. – P. 968-972.Insulin Lispro Lowers Postprandial Glucose in Prepubertal Children With Diabetes / L.C. Deeb [et al.] // PEDIATRICS. – 2001. – Vol. 108. – № 5. – P. 1175-1179.Insulin Lispro Lowers Postprandial Glucose in Prepubertal Children With Diabetes / L.C. Deeb [et al.] // PEDIATRICS. – 2001. – Vol. 108. – № 5. – P. 1175-1179.Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial / T. Battelino [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – № 7. – P. 1263-1270.Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial / T. Battelino [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – № 7. – P. 1263-1270.Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes / B. Predieri [и др.] // Frontiers in Endocrinology. – 2018. – Т. 9. – С. 462.Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes / B. Predieri [и др.] // Frontiers in Endocrinology. – 2018. – Т. 9. – С. 462.The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials / N. Thalange [et al.] // Pediatric Diabetes. – 2019. – Vol. 20. – № 3. – P. 314-320.The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials / N. Thalange [et al.] // Pediatric Diabetes. – 2019. – Vol. 20. – № 3. – P. 314-320.Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes: IDeg effective and safe in pediatric T1D / N. Thalange [et al.] // Pediatric Diabetes. – 2015. – Vol. 16. – № 3. – P. 164-176.Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes: IDeg effective and safe in pediatric T1D / N. Thalange [et al.] // Pediatric Diabetes. – 2015. – Vol. 16. – № 3. – P. 164-176.Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes / T. Danne [et al.] // Diabetes Care. – 2003. – Vol. 26. – № 11. – P. 3087-3092.Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes / T. Danne [et al.] // Diabetes Care. – 2003. – Vol. 26. – № 11. – P. 3087-3092.Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes / K.J. Robertson [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2007. – Vol. 24. – № 1. – P. 27-34.Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes / K.J. Robertson [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2007. – Vol. 24. – № 1. – P. 27-34.ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes / T. Danne [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 115-135.ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes / T. Danne [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 115-135.Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group // The Journal of Pediatrics. – 1994. – Vol. 125. – № 2. – P. 177-188.Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group // The Journal of Pediatrics. – 1994. – Vol. 125. – № 2. – P. 177-188.Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial / G. Musen [et al.] // Diabetes Care. – 2008. – Vol. 31. – № 10. – P. 1933-1938.Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial / G. Musen [et al.] // Diabetes Care. – 2008. – Vol. 31. – № 10. – P. 1933-1938.Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) / N.H. White [et al.] // The Journal of Pediatrics. – 2001. – Vol. 139. – № 6. – P. 804-812.Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) / N.H. White [et al.] // The Journal of Pediatrics. – 2001. – Vol. 139. – № 6. – P. 804-812.Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) / R. Pop-Busui [et al.] // Circulation. – 2009. – Vol. 119. – № 22. – P. 2886-2893.Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) / R. Pop-Busui [et al.] // Circulation. – 2009. – Vol. 119. – № 22. – P. 2886-2893.Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis / K. Nørgaard [et al.] // Diabetes Therapy. – 2018. – Vol. 9. – № 3. – P. 891-917.Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis / K. Nørgaard [et al.] // Diabetes Therapy. – 2018. – Vol. 9. – № 3. – P. 891-917.Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin / H.P. Chase [et al.] // The Journal of Pediatrics. – 2003. – Vol. 143. – № 6. – P. 737-740.Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin / H.P. Chase [et al.] // The Journal of Pediatrics. – 2003. – Vol. 143. – № 6. – P. 737-740.Техника инъекций и инфузии при лечении сахарного диабета. Методическое руководство. / Майоров А.Ю. [и др.]. – Москва: ООО «АРТИНФО», 2018. – 64 с.Техника инъекций и инфузии при лечении сахарного диабета. Методическое руководство. / Майоров А.Ю. [и др.]. – Москва: ООО «АРТИНФО», 2018. – 64 с.New Insulin Delivery Recommendations / A.H. Frid [et al.] // Mayo Clinic Proceedings. – 2016. – Vol. 91. – № 9. – P. 1231-1255.New Insulin Delivery Recommendations / A.H. Frid [et al.] // Mayo Clinic Proceedings. – 2016. – Vol. 91. – № 9. – P. 1231-1255.Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants / K.M. Miller [et al.] // Diabetes Care. – 2013. – Vol. 36. – № 7. – P. 2009-2014.Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants / K.M. Miller [et al.] // Diabetes Care. – 2013. – Vol. 36. – № 7. – P. 2009-2014.Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes / R. Ziegler [et al.] // Pediatric Diabetes. – 2011. – Vol. 12. – № 1. – P. 11-17.Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes / R. Ziegler [et al.] // Pediatric Diabetes. – 2011. – Vol. 12. – № 1. – P. 11-17.Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes / B. Bohn [et al.] // PloS One. – 2016. – Vol. 11. – № 8. – P. e0160971.Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes / B. Bohn [et al.] // PloS One. – 2016. – Vol. 11. – № 8. – P. e0160971.The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial / T. Battelino [et al.] // Diabetologia. – 2012. – Vol. 55. – № 12. – P. 3155-3162.The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial / T. Battelino [et al.] // Diabetologia. – 2012. – Vol. 55. – № 12. – P. 3155-3162.Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring / A.H. El-Laboudi [et al.] // Diabetes Technology & Therapeutics. – 2016. – Vol. 18. – № 12. – P. 806-812.Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring / A.H. El-Laboudi [et al.] // Diabetes Technology & Therapeutics. – 2016. – Vol. 18. – № 12. – P. 806-812.Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase / R.M. Bergenstal [et al.] // Diabetes Care. – 2011. – Vol. 34. – № 11. – P. 2403-2405.Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase / R.M. Bergenstal [et al.] // Diabetes Care. – 2011. – Vol. 34. – № 11. – P. 2403-2405.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents / H. Phelan [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 75-83.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents / H. Phelan [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 75-83.Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials / K. Winkley [et al.] // BMJ (Clinical research ed.). – 2006. – Vol. 333. – № 7558. – P. 65.Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials / K. Winkley [et al.] // BMJ (Clinical research ed.). – 2006. – Vol. 333. – № 7558. – P. 65.Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review / S.E. Hampson [et al.] // Health Technology Assessment (Winchester, England). – 2001. – Vol. 5. – № 10. – P. 1-79.Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review / S.E. Hampson [et al.] // Health Technology Assessment (Winchester, England). – 2001. – Vol. 5. – № 10. – P. 1-79.DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial / DAFNE Study Group // Diabetic Medicine: A Journal of the British Diabetic Association. – 2003. – Vol. 20 Suppl 3. – P. 4-5.DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial / DAFNE Study Group // Diabetic Medicine: A Journal of the British Diabetic Association. – 2003. – Vol. 20 Suppl 3. – P. 4-5.Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials / E. Pańkowska [et al.] // Pediatric Diabetes. – 2009. – Vol. 10. – № 1. – P. 52-58.Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials / E. Pańkowska [et al.] // Pediatric Diabetes. – 2009. – Vol. 10. – № 1. – P. 52-58.Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis / K. Benkhadra [et al.] // Endocrine. – 2017. – Vol. 55. – № 1. – P. 77-84.Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis / K. Benkhadra [et al.] // Endocrine. – 2017. – Vol. 55. – № 1. – P. 77-84.Pickup, J.C. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion / J.C. Pickup, A.J. Sutton // Diabetic medicine: a journal of the British Diabetic Association. – 2008. – Vol. 25. – № 7. – P. 765-774.Pickup, J.C. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion / J.C. Pickup, A.J. Sutton // Diabetic medicine: a journal of the British Diabetic Association. – 2008. – Vol. 25. – № 7. – P. 765-774.The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes / M.D.R. Vallejo-Mora [et al.] // Journal of Diabetes. – 2017. – Vol. 9. – № 1. – P. 24-33.The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes / M.D.R. Vallejo-Mora [et al.] // Journal of Diabetes. – 2017. – Vol. 9. – № 1. – P. 24-33.Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study) / M.D.R. Vallejo Mora [et al.] // Diabetes Technology & Therapeutics. – 2017. – Vol. 19. – № 7. – P. 402-409.Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study) / M.D.R. Vallejo Mora [et al.] // Diabetes Technology & Therapeutics. – 2017. – Vol. 19. – № 7. – P. 402-409.Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial / R. Ziegler [et al.] // Diabetes Care. – 2013. – Vol. 36. – № 11. – P. 3613-3619.Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial / R. Ziegler [et al.] // Diabetes Care. – 2013. – Vol. 36. – № 11. – P. 3613-3619.Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study / S. Schmidt [et al.] // Diabetes Care. – 2012. – Vol. 35. – № 5. – P. 984-990.Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study / S. Schmidt [et al.] // Diabetes Care. – 2012. – Vol. 35. – № 5. – P. 984-990.The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review / A. Ramotowska [et al.] // Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association. – 2013. – Vol. 121. – № 5. – P. 248-254.The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review / A. Ramotowska [et al.] // Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association. – 2013. – Vol. 121. – № 5. – P. 248-254.A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data / J.C. Wong [et al.] // Diabetes Technology & Therapeutics. – 2015. – Vol. 17. – № 8. – P. 555-562.A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data / J.C. Wong [et al.] // Diabetes Technology & Therapeutics. – 2015. – Vol. 17. – № 8. – P. 555-562.Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study / R.H. Slover [et al.] // Pediatric Diabetes. – 2012. – Vol. 13. – № 1. – P. 6-11.Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study / R.H. Slover [et al.] // Pediatric Diabetes. – 2012. – Vol. 13. – № 1. – P. 6-11.Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial / T.T. Ly [et al.] // JAMA. – 2013. – Vol. 310. – № 12. – P. 1240-1247.Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial / T.T. Ly [et al.] // JAMA. – 2013. – Vol. 310. – № 12. – P. 1240-1247.Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes / M.B. Abraham [et al.] // Diabetes Care. – 2018. – Vol. 41. – № 2. – P. 303-310.Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes / M.B. Abraham [et al.] // Diabetes Care. – 2018. – Vol. 41. – № 2. – P. 303-310.Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial / T. Battelino [et al.] // Diabetes Care. – 2017. – Vol. 40. – № 6. – P. 764-770.Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial / T. Battelino [et al.] // Diabetes Care. – 2017. – Vol. 40. – № 6. – P. 764-770.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies / J.L. Sherr [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 302-325.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies / J.L. Sherr [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 302-325.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents / H. Phelan [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 75-83.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents / H. Phelan [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 75-83.Błazik, M. The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT / M. Błazik, E. Pańkowska // Pediatric Diabetes. – 2012. – Vol. 13. – № 7. – P. 534-539.Błazik, M. The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT / M. Błazik, E. Pańkowska // Pediatric Diabetes. – 2012. – Vol. 13. – № 7. – P. 534-539.Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes / T. Battelino [et al.] // Diabetes Care. – 2011. – Vol. 34. – № 4. – P. 795-800.Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes / T. Battelino [et al.] // Diabetes Care. – 2011. – Vol. 34. – № 4. – P. 795-800.Pickup, J.C. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data / J.C. Pickup, S.C. Freeman, A.J. Sutton // BMJ (Clinical research ed.). – 2011. – Vol. 343. – P. d3805.Pickup, J.C. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data / J.C. Pickup, S.C. Freeman, A.J. Sutton // BMJ (Clinical research ed.). – 2011. – Vol. 343. – P. d3805.Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study / I.B. Hirsch [et al.] // Diabetes Technology & Therapeutics. – 2008. – Vol. 10. – № 5. – P. 377-383.Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study / I.B. Hirsch [et al.] // Diabetes Technology & Therapeutics. – 2008. – Vol. 10. – № 5. – P. 377-383.Use of the GlucoWatch biographer in children with type 1 diabetes / H.P. Chase [et al.] // Pediatrics. – 2003. – Vol. 111. – № 4 Pt 1. – P. 790-794.Use of the GlucoWatch biographer in children with type 1 diabetes / H.P. Chase [et al.] // Pediatrics. – 2003. – Vol. 111. – № 4 Pt 1. – P. 790-794.A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects / F.R. Kaufman [et al.] // Diabetes Care. – 2001. – Vol. 24. – № 12. – P. 2030-2034.A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects / F.R. Kaufman [et al.] // Diabetes Care. – 2001. – Vol. 24. – № 12. – P. 2030-2034.Ludvigsson, J. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study / J. Ludvigsson, R. Hanas // Pediatrics. – 2003. – Vol. 111. – № 5 Pt 1. – P. 933-938.Ludvigsson, J. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study / J. Ludvigsson, R. Hanas // Pediatrics. – 2003. – Vol. 111. – № 5 Pt 1. – P. 933-938.ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes / C.E. Smart [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 136-154.ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes / C.E. Smart [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 136-154.Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus / J.I. Mann [et al.] // Nutrition, metabolism, and cardiovascular diseases: NMCD. – 2004. – Vol. 14. – № 6. – P. 373-394.Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus / J.I. Mann [et al.] // Nutrition, metabolism, and cardiovascular diseases: NMCD. – 2004. – Vol. 14. – № 6. – P. 373-394.Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial / L.M. Delahanty [et al.] // The American Journal of Clinical Nutrition. – 2009. – Vol. 89. – № 2. – P. 518-524.Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial / L.M. Delahanty [et al.] // The American Journal of Clinical Nutrition. – 2009. – Vol. 89. – № 2. – P. 518-524.Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era / K.J. Bell [et al.] // Diabetes Care. – 2015. – Vol. 38. – № 6. – P. 1008-1015.Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era / K.J. Bell [et al.] // Diabetes Care. – 2015. – Vol. 38. – № 6. – P. 1008-1015.Nansel, T.R. Greater diet quality is associated with more optimal glycemic control in a longitudinal study of youth with type 1 diabetes / T.R. Nansel, L.M. Lipsky, A. Liu // The American Journal of Clinical Nutrition. – 2016. – Vol. 104. – № 1. – P. 81-87.Nansel, T.R. Greater diet quality is associated with more optimal glycemic control in a longitudinal study of youth with type 1 diabetes / T.R. Nansel, L.M. Lipsky, A. Liu // The American Journal of Clinical Nutrition. – 2016. – Vol. 104. – № 1. – P. 81-87.Increasing the protein quantity in a meal results in dose-dependent effects on postprandial glucose levels in individuals with Type 1 diabetes mellitus / M.A. Paterson [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2017. – Vol. 34. – № 6. – P. 851-854.Increasing the protein quantity in a meal results in dose-dependent effects on postprandial glucose levels in individuals with Type 1 diabetes mellitus / M.A. Paterson [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2017. – Vol. 34. – № 6. – P. 851-854.Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive / C.E.M. Smart [et al.] // Diabetes Care. – 2013. – Vol. 36. – № 12. – P. 3897-3902.Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive / C.E.M. Smart [et al.] // Diabetes Care. – 2013. – Vol. 36. – № 12. – P. 3897-3902.Pańkowska, E. Does the Fat-Protein Meal Increase Postprandial Glucose Level in Type 1 Diabetes Patients on Insulin Pump: The Conclusion of a Randomized Study / E. Pańkowska, M. Błazik, L. Groele // Diabetes Technology & Therapeutics. – 2012. – Vol. 14. – № 1. – P. 16-22.Pańkowska, E. Does the Fat-Protein Meal Increase Postprandial Glucose Level in Type 1 Diabetes Patients on Insulin Pump: The Conclusion of a Randomized Study / E. Pańkowska, M. Błazik, L. Groele // Diabetes Technology & Therapeutics. – 2012. – Vol. 14. – № 1. – P. 16-22.Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach: Hvidoere group studies / F. Cameron [et al.] // Pediatric Diabetes. – 2013. – Vol. 14. – № 7. – P. 473-480.Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach: Hvidoere group studies / F. Cameron [et al.] // Pediatric Diabetes. – 2013. – Vol. 14. – № 7. – P. 473-480.Physical activity interventions in children and young people with Type 1 diabetes mellitus: a systematic review with meta-analysis / H. Quirk [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2014. – Vol. 31. – № 10. – P. 1163-1173.Physical activity interventions in children and young people with Type 1 diabetes mellitus: a systematic review with meta-analysis / H. Quirk [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2014. – Vol. 31. – № 10. – P. 1163-1173.A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy / F. MacMillan [et al.] // Pediatric Diabetes. – 2014. – Vol. 15. – № 3. – P. 175-189.A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy / F. MacMillan [et al.] // Pediatric Diabetes. – 2014. – Vol. 15. – № 3. – P. 175-189.Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis / M. Nocon [et al.] // European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. – 2008. – Vol. 15. – № 3. – P. 239-246.Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis / M. Nocon [et al.] // European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. – 2008. – Vol. 15. – № 3. – P. 239-246.Riddell, M.C. Type 1 Diabetes and Vigorous Exercise: Applications of Exercise Physiology to Patient Management / M.C. Riddell, B.A. Perkins // Canadian Journal of Diabetes. – 2006. – Vol. 30. – № 1. – P. 63-71.Riddell, M.C. Type 1 Diabetes and Vigorous Exercise: Applications of Exercise Physiology to Patient Management / M.C. Riddell, B.A. Perkins // Canadian Journal of Diabetes. – 2006. – Vol. 30. – № 1. – P. 63-71.ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes / P. Adolfsson [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 205-226.ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes / P. Adolfsson [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 205-226.Eating problems in adolescents with Type 1 diabetes: a systematic review with meta-analysis / V. Young [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2013. – Vol. 30. – № 2. – P. 189-198.Eating problems in adolescents with Type 1 diabetes: a systematic review with meta-analysis / V. Young [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2013. – Vol. 30. – № 2. – P. 189-198.Depression and adherence to treatment in diabetic children and adolescents: a systematic review and meta-analysis of observational studies / C. Kongkaew [et al.] // European Journal of Pediatrics. – 2014. – Vol. 173. – № 2. – P. 203-212.Depression and adherence to treatment in diabetic children and adolescents: a systematic review and meta-analysis of observational studies / C. Kongkaew [et al.] // European Journal of Pediatrics. – 2014. – Vol. 173. – № 2. – P. 203-212.ISPAD Clinical Practice Consensus Guidelines 2018: The delivery of ambulatory diabetes care to children and adolescents with diabetes / C. Pihoker [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 84-104.ISPAD Clinical Practice Consensus Guidelines 2018: The delivery of ambulatory diabetes care to children and adolescents with diabetes / C. Pihoker [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 84-104.Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006 / Y.H. Cho [et al.] // Pediatric Diabetes. – 2011. – Vol. 12. – № 8. – P. 682-689.Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006 / Y.H. Cho [et al.] // Pediatric Diabetes. – 2011. – Vol. 12. – № 8. – P. 682-689.ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents / K.C. Donaghue [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 262-274.ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents / K.C. Donaghue [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 262-274.Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association / J.L. Chiang [et al.] // Diabetes Care. – 2018. – Vol. 41. – № 9. – P. 2026-2044.Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association / J.L. Chiang [et al.] // Diabetes Care. – 2018. – Vol. 41. – № 9. – P. 2026-2044.Martinez‐Zapata M. J. et al. Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy //Cochrane Database of Systematic Reviews. – 2014. – №. 11.Martinez‐Zapata M. J. et al. Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy //Cochrane Database of Systematic Reviews. – 2014. – №. 11.Simunovic, M. P., & Maberley, D. A. L. (2015). ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY. Retina, 35(10), 1931–1942. doi:10.1097/iae.0000000000000723.Simunovic, M. P., & Maberley, D. A. L. (2015). ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY. Retina, 35(10), 1931–1942. doi:10.1097/iae.0000000000000723.Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus / J. Cook [et al.] // The Journal of Pediatrics. – 1990. – Vol. 117. – № 1. – P. 39-45.Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus / J. Cook [et al.] // The Journal of Pediatrics. – 1990. – Vol. 117. – № 1. – P. 39-45.Enalapril reduces microalbuminuria in young normotensive Type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect / S. Rudberg [et al.] // Diabetologia. – 1990. – Vol. 33. – № 8. – P. 470-476.Enalapril reduces microalbuminuria in young normotensive Type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect / S. Rudberg [et al.] // Diabetologia. – 1990. – Vol. 33. – № 8. – P. 470-476.American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018 / American Diabetes Association // Diabetes Care. – 2018. – Vol. 41. – № Supplement 1. – P. S105-S118.American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018 / American Diabetes Association // Diabetes Care. – 2018. – Vol. 41. – № Supplement 1. – P. S105-S118.A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension / B. Soffer [et al.] // American Journal of Hypertension. – 2003. – Vol. 16. – № 10. – P. 795-800.A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension / B. Soffer [et al.] // American Journal of Hypertension. – 2003. – Vol. 16. – № 10. – P. 795-800.Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses / F. Catalá-López [et al.] // PLOS Medicine. – 2016. – Vol. 13. – № 3. – P. e1001971.Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses / F. Catalá-López [et al.] // PLOS Medicine. – 2016. – Vol. 13. – № 3. – P. e1001971.Finn, B.P. Supraventricular tachycardia as a complication of severe diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes / B.P. Finn, B. Fraser, S.M. O’Connell // BMJ Case Reports. – 2018. – P. bcr-2017-222861.Finn, B.P. Supraventricular tachycardia as a complication of severe diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes / B.P. Finn, B. Fraser, S.M. O’Connell // BMJ Case Reports. – 2018. – P. bcr-2017-222861.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state / J.I. Wolfsdorf [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 155-177.ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state / J.I. Wolfsdorf [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 155-177.ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes / M.B. Abraham [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 178-192.ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes / M.B. Abraham [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 178-192.Tinti, D. Mini-doses of glucagon to prevent hypoglycemia in children with type 1 diabetes refusing food: a case series / D. Tinti, I. Rabbone // Acta Diabetologica. – 2019.Tinti, D. Mini-doses of glucagon to prevent hypoglycemia in children with type 1 diabetes refusing food: a case series / D. Tinti, I. Rabbone // Acta Diabetologica. – 2019.Thyroid autoimmunity in Type 1 diabetes: systematic review and meta-analysis / C.B. Shun [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2014. – Vol. 31. – № 2. – P. 126-135.Thyroid autoimmunity in Type 1 diabetes: systematic review and meta-analysis / C.B. Shun [et al.] // Diabetic Medicine: A Journal of the British Diabetic Association. – 2014. – Vol. 31. – № 2. – P. 126-135.Lee, J.Y. Prognostic value of acoustic structure quantification in patients with Hashimoto’s thyroiditis / J.Y. Lee, H.S. Hong, C.-H. Kim // European Radiology. – 2019. – Vol. 29. – № 11. – P. 5971-5980.Lee, J.Y. Prognostic value of acoustic structure quantification in patients with Hashimoto’s thyroiditis / J.Y. Lee, H.S. Hong, C.-H. Kim // European Radiology. – 2019. – Vol. 29. – № 11. – P. 5971-5980.ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes / F.H. Mahmud [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 275-286.ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes / F.H. Mahmud [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 275-286.Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review / A. Pham-Short [et al.] // PEDIATRICS. – 2015. – Vol. 136. – № 1. – P. e170-e176.Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review / A. Pham-Short [et al.] // PEDIATRICS. – 2015. – Vol. 136. – № 1. – P. e170-e176.Elkabbany Z. A. et al. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus //Journal of Diabetes and its Complications. – 2017. – Т. 31. – №. 1. – С. 186-194.Elkabbany Z. A. et al. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus //Journal of Diabetes and its Complications. – 2017. – Т. 31. – №. 1. – С. 186-194.

The authors declare that there are no conflicts of interest present.